Hostname: page-component-89b8bd64d-shngb Total loading time: 0 Render date: 2026-05-06T19:45:24.544Z Has data issue: false hasContentIssue false

High Prevalence of Peroneal Neuropathy Among Children During the COVID-19 Pandemic

Published online by Cambridge University Press:  14 July 2022

Alberto Alemán*
Affiliation:
Division of Neurology, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada
Elisa Nigro
Affiliation:
Division of Neurology, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada
Hernán D. Gonorazky
Affiliation:
Division of Neurology, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada
*
Corresponding author: Alberto Alemán, Division of Neurology, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada. Email: alberto.aleman@sickkids.ca
Rights & Permissions [Opens in a new window]

Abstract:

Objectives:

We aimed to explore the prevalence of peroneal neuropathy in children during coronavirus disease-19 (COVID-19) pandemic.

Background:

Since the COVID-19 outbreak, many children worldwide have experienced a dramatic lifestyle changes, including conducting most daily activities indoors. Peroneal nerve palsy is one of the most common entrapment neuropathies and circumstances as prolonged immobilization or leg crossing predisposes an individual to peroneal neuropathy.

Methods:

This is a case–control retrospective study that included patients referred to our neurophysiology clinic with foot drop. We compared the prevalence of spontaneous peroneal neuropathy 1 year before (April 2019/March 2020) and 1 year during the COVID-19 pandemic (April 2020/March 2021); and we also continued collecting data prospectively between April and September 2021 analysis the whole pandemic period.

Results:

Totally, 399 patient clinical notes and NCS/EMG reports were reviewed, 220 were evaluated 1 year before and 179 1 year during COVID-19 pandemic. During the COVID-19 pandemic, there was a higher prevalence of peroneal neuropathy (odds ratio 4.74, 95%CI 1.30–17.25, p = 0.0183). In the COVID group (n = 11), mean age was 14 years and 63.4% were males. Mean age was 15 years and 66.7% were males in the Control group (n = 3). There was a significant difference in the time from symptoms onset to the neurophysiology assessment, with a mean time of 14 days in the Control group and 87.5 days in the COVID group.

Conclusions:

This study provides evidence that during the COVID-19 pandemic period, there was a higher prevalence of peroneal neuropathy among children. Strategies to prevent peroneal neuropathy should be recommened to this age group.

Résumé :

RÉSUMÉ :

Forte prévalence d’une neuropathie du sciatique poplité externe chez les enfants durant la pandémie de COVID-19.

Objectif :

L’étude visait à examiner la prévalence d’une neuropathie du sciatique poplité externe (SPE [nerf péronier]) chez les enfants durant la pandémie de la maladie à coronavirus 2019 (COVID-19).

Contexte :

Depuis la flambée de COVID-19, un grand nombre d’enfants ont connu partout dans le monde des changements considérables de leur mode de vie, notamment la pratique de la plupart des activités quotidiennes à l’intérieur. La paralysie du SPE est l’une des formes les plus courantes de neuropathie de compression, et des facteurs comme l’immobilisation prolongée ou le croisement des jambes favorisent une neuropathie du SPE.

Méthode :

Il s’agit d’une étude rétrospective, cas/témoins, de patients dirigés vers le service de neurophysiologie de l’établissement, pour pied tombant. Ainsi, la prévalence d’une neuropathie spontanée du SPE durant l’année précédant la pandémie (avril 2019-mars 2020) a été comparée avec celle enregistrée durant l’année de la pandémie de COVID-19 (avril 2020-mars 2021), et la collecte de données s’est poursuivie de manière prospective, entre avril et septembre 2021, en vue d’une analyse couvrant toute la période de la pandémie.

Résultats :

Ont été examinés 399 observations cliniques et rapports d’analyse de neuroconduction et d’électromyographie : 220 datant de l’année précédente et 179 datant de l’année de la pandémie. Une augmentation de la prévalence d’une neuropathie du SPE (risque relatif approché : 4,74; IC à 95 % : 1,30–17,25; p = 0,0183) a été observée durant cette dernière année. Dans le groupe COVID (n = 11), l’âge moyen était de 14 ans et il y avait 63,4 % de garçons; dans le groupe témoin (n = 3), l’âge moyen était de 15 ans et il y avait 66,7 % de garçons. Un écart significatif du temps écoulé depuis l’apparition des symptômes jusqu’à l’évaluation en neurophysiologie a été relevé entre le groupe témoin et le groupe COVID, attente qui s’est établie respectivement à 14 jours et à 87,5 jours.

Conclusion :

Les résultats de l’étude confirment bien qu’il y a eu une augmentation d’une neuropathie du SPE chez les enfants, durant la pandémie de COVID-19. Il faudrait que soient recommandées des stratégies de prévention d’une neuropathie du SPE aux jeunes de ce groupe d’âge.

Information

Type
Original Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of Canadian Neurological Sciences Federation
Figure 0

Figure 1: Study flowchart. Charts reviewed and identified referrals of patients with foot drop and confirmed peroneal neuropathy. Totally, 399 charts were retrospectively reviewed (continuous line) and 111 charts were prospectively reviewed (dashed line).

Figure 1

Table 1: Demographic and clinical characteristics.

Figure 2

Table 2: Electrophysiologic features found in patients with foot drop.

Figure 3

Figure 2: Cases of peroneal neuropathy per season 1 year previous to the outbreak of the COVID-19 pandemic in Ontario (green), during the first year of the pandemic (dark gray) and prospective follow-up until summer 2021 (light blue). The year previous to the pandemic outbreak is shown in light green; the states of emergencies during the pandemic period are shown in red (the first one was declared from March 17 to July 24, 2020; and the second state of emergency was declared from January 12 to February 10, 2021); and the gradual lifting of the government restrictions are shown in yellow. Prevalence of spontaneus peroneal neuropathy in the COVID group versus the Control group: odds ratio 4.74, 95% CI 1.30–17.25, p =c0.0183. Prevalence of spontaneus peroneal neuropathy in the whole pandemic period versus the Control group: odds ratio 3.95, 95% CI 1.13–13.80, p = 0.0317.

Supplementary material: PDF

Alemán et al. supplementary material

Alemán et al. supplementary material

Download Alemán et al. supplementary material(PDF)
PDF 263.3 KB